Lobbying Information
Subject Matters
- Economic Development
- Health
- Industry
- Intellectual Property
- International Trade
- Research and Development
- Science and Technology
Subject Matter Details
Legislative Proposal, Bill or Resolution
- Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
Policies or Program
- Health Canada guidelines and administrative practices with respect to the approval, regulation and life-cycle management of therapeutic products
- Health system policies with respect to public health and vaccine development, market authorization, and manufacturing
- Innovation agenda led by Innovation, Science and Economic Development Canada, particularly with respect to partnerships and funding opportunities for the life sciences
Regulation
- Clinical trials regulations and associated guidelines
- Food and Drugs Regulations, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Innovation, Science and Economic Development Canada (ISED)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Public Health Agency of Canada (PHAC)
-
Senate of Canada
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
661 University Avenue, Suite 1300
Toronto, ON M5G 0B7
Canada
Telephone number:
403-714-1724
Web address:
https://www.providencetherapeutics.com/
Client representative
Ken Hughes, Chair of the Board
Parent Company Information
Providence Therapeutics Inc. is not a subsidiary of any other parent companies.
Coalition Members Information
Providence Therapeutics Inc. is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Providence Therapeutics Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Providence Therapeutics Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
Stephen Sampson
|
Public offices held
Business address:
50 O'Connor St., Suite 901
Ottawa, ON K1P 6L2
Canada
Telephone number:
613-782-2336
Consultant Firm and Address
Firm:
Global Public Affairs
Address:
50 O'Connor St., Suite 901
Ottawa, ON K1P 6L2
Canada
Telephone number:
613-782-2336